KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AmortizationAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Other financing activities (2018 - 2025)

Historic Other financing activities for Aurora Cannabis (ACB) over the last 5 years, with Q3 2024 value amounting to -$96030.0.

  • Aurora Cannabis' Other financing activities changed N/A to -$96030.0 in Q3 2024 from the same period last year, while for Mar 2025 it was -$228126.2, marking a year-over-year increase of 1226.77%. This contributed to the annual value of -$91296.1 for FY2025, which is 7410.07% up from last year.
  • According to the latest figures from Q3 2024, Aurora Cannabis' Other financing activities is -$96030.0.
  • In the past 5 years, Aurora Cannabis' Other financing activities registered a high of $489697.5 during Q2 2020, and its lowest value of -$287915.3 during Q1 2020.
  • For the 4-year period, Aurora Cannabis' Other financing activities averaged around -$27772.7, with its median value being -$66462.6 (2023).
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 11119.23% in 2020, then tumbled by 84395.86% in 2023.
  • Aurora Cannabis' Other financing activities (Quarter) stood at $489697.5 in 2020, then plummeted by 98.04% to $9577.1 in 2022, then tumbled by 843.96% to -$71249.9 in 2023, then crashed by 34.78% to -$96030.0 in 2024.
  • Its Other financing activities stands at -$96030.0 for Q3 2024, versus -$132096.2 for Q1 2024 and -$71249.9 for Q4 2023.